Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up

BACKGROUND: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%. However, the occurrence of a late thrombosis can compromise long-term results, par...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrini, Denise Oliveira, Gomes, Vitor Osório, Lasevitch, Ricardo, Smidt, Luis, Azeredo, Marco Aurélio, Ledur, Priscila, Bodanese, Rodrigo, Sinnott, Leonardo, Moriguchi, Emílio, Caramori, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193064/
https://www.ncbi.nlm.nih.gov/pubmed/25098375
http://dx.doi.org/10.5935/abc.20140110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193064/
https://www.ncbi.nlm.nih.gov/pubmed/25098375
http://dx.doi.org/10.5935/abc.20140110

Ejemplares similares